Literature DB >> 3138801

Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.

L B Heifets1, P J Lindholm-Levy.   

Abstract

MICs of ciprofloxacin were lower than MICs of ofloxacin for both M. tuberculosis and M. avium complex strains. The MICs of both drugs for 41 M. tuberculosis strains were in a narrow range, and significantly lower than the achievable serum concentrations. The MICs of ciprofloxacin for 46 M. avium strains were in a wide range, and in only 28% were the broth-determined MICs of ciprofloxacin within the same range as for M. tuberculosis and lower than the achievable serum level. When compared with the concentrations achievable in macrophages, the broth-determined MICs of ciprofloxacin were lower than this level for 61% of M. avium strains. Both drugs were bactericidal against M. tuberculosis and M. avium, with a low MIC/MBC ratio.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3138801     DOI: 10.1016/0041-3879(87)90067-5

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  29 in total

1.  Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors:  G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy.

Authors:  T J Borody; L B Heifets
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.

Authors:  H Tomioka; K Sato; H Saito
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 4.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

5.  Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.

Authors:  J Conley; H Yang; T Wilson; K Blasetti; V Di Ninno; G Schnell; J P Wong
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

6.  Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice.

Authors:  C B Inderlied; P T Kolonoski; M Wu; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

7.  Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.

Authors:  S H Siddiqi; L B Heifets; M H Cynamon; N M Hooper; A Laszlo; J P Libonati; P J Lindholm-Levy; N Pearson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.

Authors:  L E Bermudez; C B Inderlied; P Kolonoski; M Wu; L Barbara-Burnham; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.

Authors:  N Rastogi; K S Goh
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.

Authors:  H Tomioka; H Saito; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.